Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00370695 · ClinicalTrials.gov registry record · NA

Spinal Cord Stimulation for Chronic and Intractable Back Pain

A NA study, sponsored by Boston Scientific Corporation.

Terminated
Registry status
NA
Development phase
15
Enrollment target

NCT00370695 is a NA study that was terminated before completion, run by Boston Scientific Corporation. The registered enrollment target is 15 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00370695, a NA study, was terminated before completion, sponsored by Boston Scientific Corporation.

TERMINATED
Registry status
NA
Development phase
15 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the efficacy of spinal cord stimulation (SCS) using the Precision implantable neurostimulation device for chronic and intractable back pain in subjects who are not candidates for surgery or who have chosen to seek alternative therapy.

Interventions

  • DEVICE Precision Spinal Cord Stimulation System

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2006-02
Est. Completion 2008-07
Phase NA

Sponsor

Boston Scientific Corporation

280 total trials

What the Registry Record Tells You About NCT00370695

The ClinicalTrials.gov registry entry for NCT00370695 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Precision Spinal Cord Stimulation System is the first listed.

NCT00370695 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00370695 about?

NCT00370695 is a clinical study titled "Spinal Cord Stimulation for Chronic and Intractable Back Pain". The purpose of this study is to evaluate the efficacy of spinal cord stimulation (SCS) using the Precision implantable neurostimulation device for chronic and intractable back pain in subjects who are not candidates for surgery or who have chosen to seek alternative therapy.

What is the current status of trial NCT00370695?

This trial is currently terminated. It is a NA study. The enrollment target is 15 participants. The study started on 2006-02. Estimated completion is 2008-07.

What interventions are being tested in trial NCT00370695?

The interventions under investigation include: Precision Spinal Cord Stimulation System (DEVICE).

Who is sponsoring clinical trial NCT00370695?

This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.